REFRACTORY HEPATOBLASTOMA
Clinical trials for REFRACTORY HEPATOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY HEPATOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY HEPATOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: experimental drug trial opens
Disease control Recruiting nowThis study is testing a new drug called tegavivint in children, teens, and young adults whose solid tumors or lymphomas have come back or haven't responded to other treatments. The main goals are to find the safest dose, understand the side effects, and see if the drug can help s…
Matched conditions: REFRACTORY HEPATOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for kids with tough cancers: trial tests Double-Team drug strategy
Disease control Recruiting nowThis study is testing two different drug combinations to find safe doses and see if they can help control cancer in children and young adults whose solid tumors have come back or haven't responded to treatment. In the first part, participants will be assigned to receive either On…
Matched conditions: REFRACTORY HEPATOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC
-
Scientists build a 'Library' of tough childhood liver cancer cases
Knowledge-focused Recruiting nowThis study aims to gather detailed information and tissue samples from children whose liver cancer (hepatoblastoma) has come back or hasn't responded to treatment. By creating a central registry and sample bank, researchers hope to understand why these cancers are so difficult to…
Matched conditions: REFRACTORY HEPATOBLASTOMA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC